Single versus Combination Treatment in Tinnitus: An International, Multicentre, Parallel-arm, Superiority, Randomised Controlled Trial
Stefan Schoisswohl,Laura Basso,Jorge Simoes,Milena Engelke,Berthold Langguth,Birgit Mazurek,Jose Antonio Lopez-Escamez,Dimitrios Kikidis,Rilana Cima,Alberto Bernal-Robledano,Benjamin Boecking,Jan Bulla,Christopher Cederroth,Sam Denys,Alba Escalera-Balsera,Alvaro Gallego-Martinez,Silvano Gallus,Leire Hidalgo-Lopez,Carlotta Jarach,Hafez Kader,Michael Koller,Alessandra Lugo,Steven Marcrum,Nikos Markatos,Juan Martin-Lagos,Marta Martinez-Martinez,Nicolas Muller-Locatelli,Patrick Neff,Uli Niemann,Patricia Perez-Carpena,Ruediger Pryss,Clara Puga,Paula Robles-Bolivar,Matthias Rose,Martin Schecklmann,Tabea Schiele,Miro Schleicher,Johannes Schobel,Myra Spiliopoulou,Sabine Stark,Susanne Staudinger,Alexandra Stege,Beat Toedtli,Ilias Trochidis,Vishnu Unnikrishnan,Evgenia Vassou,Nicolas Verhaert,Carsten Vogel,Zoi Zachou,Winfried Schlee
DOI: https://doi.org/10.1101/2024.01.09.24300978
2024-08-13
Abstract:Background Tinnitus is associated with a variety of aetiologies, phenotypes, and underlying pathophysiological mechanisms, and available treatments have limited efficacy. A combination of treatments, addressing various aspects of tinnitus, might provide a viable and superior treatment strategy.
Methods In this international multicentre, parallel-arm, superiority, randomised controlled clinical trial, patients with chronic subjective tinnitus were recruited from five clinical sites across four European countries. Patients were randomly assigned using a web-based system, stratified by their hearing and distress level, to single or combination treatment of 12 weeks. Cognitive-behavioural therapy, hearing aids, structured counselling, and sound therapy were administered either alone or as a combination of two treatments resulting in ten treatment arms. The primary outcome was the difference in the change from baseline to week 12 in the total score of the Tinnitus Handicap Inventory between single and combination treatments in the intention-to-treat population. All statistical analysis were performed blinded to treatment allocation. This trial was registered at ClinicalTrials.gov ( ) and is now closed.
Findings Between Apr 16, 2021, and Sept 20, 2022, 674 patients were screened and 461 were enrolled, 230 of which were randomly assigned to single and 231 to combination treatment. Least-squares mean changes from baseline to week 12 were -11.7 for single (95% confidence interval [CI], -14.4 to -9.0) and -14.9 for combination treatments (95% CI, -17.7 to -12.1), with a significant between-group difference (p=0.034). Sound therapy alone had the lowest effect size. In contrast, cognitive-behavioural therapy and hearing aids alone had large effect sizes, which could not be further increased by combination treatment. No serious adverse events occurred.
Interpretation In this trial involving patients with chronic tinnitus, all treatment arms showed improvement in THI scores from baseline to week 12. No clear synergistic effect was observed when combining treatments, but rather a compensatory effect, where a more effective treatment offsets the clinical effects of a less effective treatment.
Funding European Union's Horizon 2020 Research and Innovation Program (grant agreement number: 848261).
Otolaryngology